Top-Ranked Bevacizumab Biosimilar Supplier for Colorectal, Lung, Ovarian & Kidney Cancer Treatment
Bevacizumab Biosimilar 100mg / 400mg Injection is a widely prescribed targeted therapy for multiple advanced cancers. If you are searching for a trusted global supplier from India, Cordium Pharmaceuticals Pvt Ltd offers premium-quality oncology medicines with fast, secure, and cost-effective worldwide delivery.
We proudly supply to hospitals, cancer clinics, pharmacies, distributors, and individual patients (personal import) across United States, Germany, United Kingdom, Netherlands, South Africa, United Arab Emirates, and Brazil.
Product Overview – Bevacizumab Biosimilar Injection
- Product Name: Bevacizumab Biosimilar Injection
- Available Strengths: 100mg / 400mg
- Dosage Form: Sterile Injectable (IV Infusion)
- Drug Class: Anti-angiogenic monoclonal antibody
- Usage: Oncology / Cancer Treatment
This biosimilar version provides a cost-effective alternative to the reference biologic while maintaining comparable safety and efficacy.
Cancer Treatments Covered by Bevacizumab Injection
Bevacizumab biosimilar is an essential component in modern oncology protocols for:
- Metastatic Colorectal Cancer Treatment
- Advanced Non-Small Cell Lung Cancer Therapy
- Recurrent Glioblastoma Brain Tumor Management
- Renal Cell Carcinoma (Kidney Cancer)
- Persistent or metastatic Cervical Cancer
- Ovarian, Fallopian Tube & Peritoneal Cancer
It is commonly combined with chemotherapy or other targeted agents to enhance treatment outcomes.
Mechanism of Action – Targeting Tumor Blood Supply
Bevacizumab works by inhibiting VEGF (Vascular Endothelial Growth Factor), a key protein responsible for tumor angiogenesis. By blocking this pathway:
- Tumor blood vessel formation is suppressed
- Nutrient and oxygen supply to cancer cells is reduced
- Tumor progression slows significantly
This makes it a critical therapy in controlling advanced-stage cancers.
Key Advantages of Bevacizumab Biosimilar
- ✔ Clinically effective targeted cancer therapy
- ✔ Helps delay disease progression
- ✔ Reduces tumor vascularization
- ✔ More affordable than innovator biologics
- ✔ Suitable for long-term oncology treatment plans
Administration & Dosage Guidelines
- Given via intravenous infusion (IV) under expert supervision
- Dosage varies depending on:
- Cancer type and stage
- Patient body weight
- Combination therapy protocol
- Must be administered in a hospital or oncology clinic setting
Safety Profile & Side Effects
Patients may experience manageable side effects such as:
- Hypertension (high blood pressure)
- Mild bleeding (e.g., nosebleeds)
- Fatigue or weakness
- Proteinuria (protein in urine)
- Delayed healing of wounds
Regular monitoring by healthcare professionals is essential for safe treatment.
Why Cordium Pharmaceuticals Pvt Ltd is Your Trusted Partner
When sourcing critical oncology medicines, reliability matters. Cordium Pharmaceuticals Pvt Ltd stands out as a dependable exporter from India:
- ✅ Expertise in global oncology medicine supply
- ✅ Strict quality assurance and certified sourcing
- ✅ Competitive bulk and retail pricing
- ✅ Fast dispatch with temperature-controlled packaging
- ✅ Worldwide logistics support with documentation
- ✅ Trusted by hospitals, clinics & international buyers
- ✅ Smooth personal import assistance for patients
International Export & Supply Network
We ensure seamless delivery of Bevacizumab Biosimilar Injection to:
- Oncology Hospitals & Cancer Institutes
- Specialty Clinics & Oncologists
- Pharmaceutical Distributors & Pharmacies
- Patients requiring personal import access
Export destinations include:
USA | Germany | UK | Netherlands | South Africa | UAE | Brazil
Order Now – Fast Response & Global Delivery
📲 WhatsApp: +91-9405117673
📧 Email: info@cordiumpharma.com
Contact us today for:
- Latest pricing and availability
- Bulk supply requirements
- Urgent export orders
- Documentation for international shipping